Drug Discovery | Analysis | By Aishwarya Venkatesh | 0 Comment | 13 May, 2015
Singapore: Dengue, also known as break bone fever, is currently the most common vector-borne disease. The World Health ...Read more
Novartis' bimagrumab gets breakthrough nod from FDA
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2013
Singapore: Novartis received US FDA breakthrough therapy designation for BYM338 (bimagrumab) for sporadic inclusion body...Read more
NMT Pharma and CAO Pharma in licensing agreement for anti-cancer drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 26 Aug, 2015
Singapore: Singapore based start-up firm, NMT Pharmaceuticals, has acquired an exclusive worldwide license right to furt...Read more
Boehringer Ingelheim, Circuit Therapeutics to invest in obesity diseases
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Aug, 2015
Singapore: Boehringer Ingelheim and Circuit Therapeutics have formed a three-year collaboration to focus on investigatin...Read more
Takeda, Enterome ink drug discovery collaboration
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Jan, 2016
Takeda Pharmaceutical Company Ltd and Paris-headquartered Enterome Bioscience SA have entered into a strategic drug disc...Read more
FDA approves additional indication of Eisai's anticancer agent Lenvima
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 17 May, 2016
Japan's Eisai Co Ltd has announced that its US subsidiary Eisai Inc. has received approval from the US Food and Drug Adm...Read more
SCIEX, NUS to jointly develop oncology biomarkers
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 18 May, 2015
Singapore: SCIEX, a global leader in life science analytical technologies, and the Protein and Proteomics Centre (PPC) u...Read more
PharmaMar seeks Japan PMDA approval for tissue sarcoma drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 02 Sep, 2015
The Japanese Pharmaceutical Affairs and Food Sanitation Council (PAFSC) has recommended an approval for Madrid-based Pha...Read more
EU recommends Opdivo as monotherapy for advance melanoma
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 27 Apr, 2015
Singapore: European Medicines Agency (EMA) has recommended granting a marketing authorisation for Bristol-Myers Squibb's...Read more
Paradigm gets US patent for bone marrow drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 26 Aug, 2015
Singapore: Australia based Paradigm Biopharmaceuticals has been granted a patent by United States Patent and Trademark O...Read more
TB claims 74000 children each year: WHO
Drug Discovery | Analysis | By BioSpectrum Bureau | 0 Comment | 02 Oct, 2013
Singapore: World Health Organization has launched "Roadmap for childhood TB: towards zero deaths", in an effort to preve...Read more
China's Yabao pharma inks deal with Australian University
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Sep, 2015
Singapore: China's leading pharmaceutical firm Yabao Pharmaceutical has inked a pact with the University of South Austra...Read more
Celgene gets Europe's nod for acute myeloid leukaemia drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Oct, 2015
Singapore: Celgene International has received European Commission (EC) approval for VIDAZA (azacitidine for injection) f...Read more
Australia's Invitrocue initiates research on Malaria
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 16 May, 2016
InvitroCue, the Australian company that works on advanced bio-analytics, has announced a key initiative on Malaria to id...Read more
Bionomics to initiate trial for antibody targeting cancer stem cell
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 31 Aug, 2015
Singapore: Bionomics, Australia based biopharmaceutical company focused on the discovery and development of innovative t...Read more
Oncology drug pipeline is the most robust'
Drug Discovery | Analysis | By BioSpectrum Bureau | 1 Comment | 06 Aug, 2015
Singapore: The oncology drug pipeline is far larger than any other therapy area across the pharmaceutical industry, with...Read more
Japanese researchers discover gold nanoparticles for cancer drug delivery
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 01 Apr, 2015
Researchers affiliated with Kawasaki Innovation Gateway at SKYFRONT, Japan have discovered that incorporating gold nanop...Read more
Astella, Potenza partner to enhance immune-oncology programs
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Apr, 2015
Singapore: Japan's Astellas Pharma and Potenza Therapeutics, a biotechnology company developing a portfolio of immuno-on...Read more